Koji Kamikozuru

Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

Kōji Yoshida, Ken Fukunaga, Hiroki Ikeuchi et al. · Inflammatory Bowel Diseases · 2011 · 151 citations · Full text

Demonstration of Low-Regulatory CD25High+CD4+ and High-Pro-inflammatory CD28−CD4+ T-Cell Subsets in Patients with Ulcerative Colitis: Modified by Selective Granulocyte and Monocyte Adsorption Apheresis

Yoko Yokoyama, Ken Fukunaga, Yoshihiro Fukuda et al. · Digestive Diseases and Sciences · 2007 · 75 citations

Inflammation, Chronic Inflammatory Diseases, Allergy +15

<i>NUDT15</i>,<i>FTO</i>, and<i>RUNX1</i>genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases

Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta et al. · Intestinal Research · 2017 · 45 citations · Full text

Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis

Ken Fukunaga, Yoshio Ohda, Nobuyuki Hida et al. · Journal of Gastroenterology and Hepatology · 2012 · 41 citations

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease

Koji Kamikozuru, Ken Fukunaga, Shigeru Hirota et al. · Clinical & Experimental Immunology · 2009 · 41 citations · Full text

Inflammation, Quiescent Disease, Rectal Mucosa +12